Gufic Biosciences Limited
Girish Gulati disclosed a 1.00% stake in Gufic Biosciences Limited, holding 10,03,800 shares. The investor now holds 1.00%, up from under 1% in the prior filing.
A pharmaceutical manufacturer engaged in producing medicinal chemicals, botanical products, and finished pharmaceutical formulations for domestic and international markets. Gufic BioScience operates across multiple therapeutic segments, focusing on research-driven drug development and manufacturing of active pharmaceutical ingredients. The company combines traditional botanical expertise with modern pharmaceutical science to deliver diverse healthcare solutions across different treatment areas.
High-conviction investor in India's defence and industrial manufacturing themes, with positions in Avantel (defence electronics), TIL (material handling equipment), and agro-chemicals, all held through personal and HUF accounts. Disclosed portfolio: ~₹366 Cr across 13 stocks. His defence thesis was in place well before 'Make in India' became a consensus trade. Minimal churn, maximum conviction.